Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Menactra Immunogenicity and Safety in Healthy Infants
NCT00384397Phase 3Completed
- Sponsor
- Sanofi
- Start
- Sep 2006
- Primary completion
- Aug 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of meningococcal A conjugate vaccine in meningococcal meningitis, sponsored by Sanofi. Started Sep 2006; status: completed.
02
Drugs
meningococcal A conjugate vaccine
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on NCT00384397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00384397.